| Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation |
Globe Newswire |
05/12 |
16:30 |
| Nexxen to Host Investor Day on June 16, 2026 |
Globe Newswire |
05/12 |
16:30 |
| LM Funding Announces First Quarter 2026 Earnings Call for May 15, 2026 |
Globe Newswire |
05/12 |
16:30 |
| Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director |
Globe Newswire |
05/12 |
16:20 |
| Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates |
Globe Newswire |
05/12 |
16:18 |
| Public Policy Holding Company, Inc. Announces Q1 2026 Financial Results |
Globe Newswire |
05/12 |
16:14 |
| Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates |
Globe Newswire |
05/12 |
16:08 |
| Lumexa Imaging Announces First Quarter 2026 Results |
Globe Newswire |
05/12 |
16:07 |
| Interpace Biosciences Announces First Quarter 2026 Financial and Business Results |
Globe Newswire |
05/12 |
16:06 |
| Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates |
Globe Newswire |
05/12 |
16:06 |
| Black Rock Coffee Bar, Inc. Reports First Quarter 2026 Results |
Globe Newswire |
05/12 |
16:06 |
| Nyxoah Reports First Quarter 2026 Financial and Operating Results |
Globe Newswire |
05/12 |
16:05 |
| Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs |
Globe Newswire |
05/12 |
16:05 |
| Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/12 |
16:05 |
| Lifecore Biomedical to Participate at CDMO Live Europe |
Globe Newswire |
05/12 |
16:05 |
| Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
16:01 |
| OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance |
Globe Newswire |
05/12 |
16:01 |
| BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today’s Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expeditiously |
Globe Newswire |
05/12 |
16:01 |
| Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees |
Globe Newswire |
05/12 |
16:01 |
| IZEA Reports Q1 2026 Revenue of $6.6 Million, Strengthens Enterprise Client Base, Launches AI-Powered ZED Platform |
Globe Newswire |
05/12 |
16:01 |
| Intermap Announces Date for First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
16:00 |
| Winners, Inc. Announces 300-1 Reverse Stock Split to Position for Strategic Growth and Future Uplisting Strategy |
Globe Newswire |
05/12 |
16:00 |
| Javatide Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk |
Globe Newswire |
05/12 |
15:58 |
| ALIT INVESTOR ALERT: Alight, Inc. Investors with Substantial Losses Have Opportunity to Lead the Alight Class Action Lawsuit – RGRD Law |
Globe Newswire |
05/12 |
15:40 |
| BloodPril: The TRUTH Behind the 'Blood Pril' Nitric Oxide Formula and What Consumers Need to Know |
Globe Newswire |
05/12 |
15:33 |
